Company news

XtalPi Holdings Limited news in 2025

XtalPi Holdings Limited's news releases, calls and decks from 2025, newest first.

View company

XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development

November 5, 2025

XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals

September 9, 2025

XtalPi Holdings Announces 2025 Interim Results

August 27, 2025

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

August 19, 2025

XtalPi Holdings Limited to Announce 2025 Interim Results on August 27, 2025

August 18, 2025

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

August 6, 2025

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

June 29, 2025

XtalPi Announces Strategic Collaboration with Harvard Professor Gregory Verdine's DoveTree LLC to Advance Novel Therapeutics Using AI+Robotics Drug Discovery Platform

June 22, 2025

XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration

June 13, 2025

XtalPi and Kula Bio Forge Multi-Million USD Collaborative R&D Agreement to Advance AI-Driven Microbial Fertilizers in China and the Middle East

March 28, 2025

Decks in 2025